See what General Motors, Mitsubishi Logisnext Americas, Genentech and other companies have been up to this month.

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

At CTO West Coast an expert from Genentech outlined the company’s net zero goals, efforts, challenges and initiatives ...

Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the ...

The ODAC cited concerns with patient populations in clinical trials used to support the proposed expansion. Johnson & Johnson ...

As the administration pushes for a return to US manufacturing, outsourcing agreements with domestic manufacturers are ...

The partnership will include $105m upfront to Orionis, with the potential for further payments that could exceed $2bn.

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Genentech is committed to helping people access the medicines they are prescribed and will be offering comprehensive services for people prescribed Susvimo to help minimize barriers to access and ...

New Two-year Follow-up of Genentech’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma Patients – Updated data from the pivotal Phase III STARGLO study ...

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...

– Updated data from the pivotal Phase III STARGLO study continue to demonstrate a clinically meaningful improvement in overall survival with a 40% survival benefit for people with R/R DLBCL who ...